Derm-Biome Pharmaceuticals, Inc. reports Positive Results from a Preclinical Study in Atopic Dermatitis: its new generation of compounds are significantly more effective than FDA-approved topical AD drug crisaborole
September 16, 2021 10:00 ET
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based biopharmaceutical company focused on skin health and healthy ageing, is pleased to...
Global $5.5 Billion Dermatology Medical Lasers Markets Analysis & Forecasts, 2015-2020, 2020-2025F, 2030F
September 16, 2021 04:43 ET
|
Research and Markets
Dublin, Sept. 16, 2021 (GLOBE NEWSWIRE) -- The "Dermatology Medical Lasers Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering....
How to Remove Unwanted Hair Using a Cream, Lotion or Gel: American Academy of Dermatology
September 14, 2021 14:30 ET
|
American Academy of Dermatology
ROSEMONT, Ill., Sept. 14, 2021 (GLOBE NEWSWIRE) -- As temperatures remain high across the country, removing unwanted body hair is still top of mind for many; however, shaving may have started to...
Pinnacle Dermatology, a Chicago Pacific Founders portfolio company, Acquires Chappell Rosso Dermatology and Laser & Aesthetic Center in Odessa, Texas.
September 14, 2021 11:38 ET
|
Pinnacle Dermatology
Brentwood, TN, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Pinnacle Dermatology, a leader in population skin health management, has acquired Chappell Rosso Dermatology and Laser & Aesthetic Center in...
South America Hydraulic Acid (HA) Based Dermal Filler Market Report 2021-2028 Featuring Merz Pharma, HUGEL, TEOXANE, Allergan, Galderma, LG Chem, Sinclair Pharma, Medytox
September 14, 2021 04:03 ET
|
Research and Markets
Dublin, Sept. 14, 2021 (GLOBE NEWSWIRE) -- The "South America Hydraulic Acid (HA) Based Dermal Filler Market Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The South...
Arcutis to Present at Upcoming Investor Conferences
September 09, 2021 16:10 ET
|
Arcutis Biotherapeutics, Inc.
WESTLAKE VILLAGE, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful innovations in...
Arcutis Announces Appointment of Keith Leonard to Board of Directors
September 02, 2021 16:10 ET
|
Arcutis Biotherapeutics, Inc.
WESTLAKE VILLAGE, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful innovations to...
Western Dermatology Consultants Adds New Dermatologist
August 30, 2021 12:02 ET
|
Western Dermatology Consultants
ALBUQUERQUE, N.M., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Skin is constantly subjected to the aging process, as well as exposed to sunlight, pollution, chemicals, toxins, weather changes, gravity, and...
Arcutis Enrolls First Patient in Phase 3 Clinical Trial of Topical Roflumilast Foam (ARQ-154) as a Potential Treatment for Scalp and Body Psoriasis
August 25, 2021 08:00 ET
|
Arcutis Biotherapeutics, Inc.
Topical roflumilast potential “Best-in-Class” topical PDE4 inhibitorScalp and body psoriasis affects more than 8 million patients in the U.S. WESTLAKE VILLAGE, Calif., Aug. 25, 2021 (GLOBE...
Novan Appoints Tomoko Maeda-Chubachi, MD, PhD, MBA as Chief Medical Officer
August 24, 2021 09:00 ET
|
Novan, Inc.
– Dr. Maeda-Chubachi, who served as Novan’s Senior Vice President, Medical has played a key role in the design and execution of the Company’s development programs – – Dr. Maeda-Chubachi was...